Biognosys AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biognosys AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10660
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biognosys AG (Biognosys) is a proteomics company which offers tools and services for highly multiplexed protein quantification. Its products portfolio includes calibration kits for reproducible mass spectrometry proteomics, and prediction of peptide retention; software support for multiple and parallel reaction monitoring (MRM and PRM) measurements. It also offers proteomics services, and contract research services for high content protein quantification and analysis. Biognosys’s Hyper Reaction Monitoring (HRM-MS), a mass spectrometry based on proteomics technology enables reproducible and precise quantification of thousands of proteins in a single instrument run with data independent acquisition. The company caters to pharmaceutical, biotechnology, diagnostics and agricultural industries. It has operations with office in Massachusetts, the US. Biognosys is headquartered in Dietikon, Switzerland.

Biognosys AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biognosys AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biognosys AG, Medical Devices Deals, 2012 to YTD 2018 9
Biognosys AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biognosys AG, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biognosys Raises Additional USD5 Million in Series C Financing 11
Biognosys Raises Funds in Series C Financing Round 12
Partnerships 13
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 13
Freenome Enters into Agreement with Biognosys 14
Biodesix Forms Partnership with Biognosys 15
AstraZeneca Partners with Biognosys 16
Biognosys Enters Into Co-Marketing Agreement With Filgen 17
Licensing Agreements 18
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 18
Biognosys AG – Key Competitors 19
Biognosys AG – Key Employees 20
Biognosys AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
Nov 08, 2017: Biognosys Announces a Technological Breakthrough in the Development of Its Next-Generation Proteomics Workflow 22
Apr 25, 2017: Biognosys re-launches its blood proteomics portfolio 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Biognosys AG, Pharmaceuticals & Healthcare, Key Facts 2
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biognosys AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biognosys AG, Deals By Therapy Area, 2012 to YTD 2018 8
Biognosys AG, Medical Devices Deals, 2012 to YTD 2018 9
Biognosys AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biognosys Raises Additional USD5 Million in Series C Financing 11
Biognosys Raises Funds in Series C Financing Round 12
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 13
Freenome Enters into Agreement with Biognosys 14
Biodesix Forms Partnership with Biognosys 15
AstraZeneca Partners with Biognosys 16
Biognosys Enters Into Co-Marketing Agreement With Filgen 17
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 18
Biognosys AG, Key Competitors 19
Biognosys AG, Key Employees 20
Biognosys AG, Subsidiaries 21

List of Figures
Biognosys AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biognosys AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biognosys AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biognosys AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biognosys AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swissgrid AG:電力:M&Aディール及び事業提携情報
    Summary Swissgrid AG (Swissgrid) is a national grid company that operates, maintains, modernizes and expands the electricity transmission system in Switzerland. It conducts the import and export of electricity to maintain the utilization levels. The company also provides additional services, such as …
  • Sberbank Rossii:企業の戦略・SWOT・財務情報
    Sberbank Rossii - Strategy, SWOT and Corporate Finance Report Summary Sberbank Rossii - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Companhia de Transmissao de Energia Eletrica Paulista (TRPL4):企業の財務・戦略的SWOT分析
    Summary Companhia de Transmissao de Energia Eletrica Paulista (CTEEP) a subsidiary of Interconexion Electrica SA ESP, is an electric utility service provider that produces and distributes electricity. The utility owns and operates power generation plants and transmission lines and supplies electrici …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Global Cardiovascular Innovation Center:医療機器:M&Aディール及び事業提携情報
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sonda SA (SONDA):企業の財務・戦略的SWOT分析
    Sonda SA (SONDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Taiwan High Speed Rail Corporation
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • BioNTech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary BioNTech AG (BioNTech) is a biopharmaceutical company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, BioNTech small molecules a …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • HUK-COBURG-Versicherungsgruppe:企業の戦略・SWOT・財務情報
    HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report Summary HUK-COBURG-Versicherungsgruppe - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PT Bakrieland Development Tbk:企業の戦略・SWOT・財務情報
    PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Black Rock Mining Ltd (BKT):企業の財務・戦略的SWOT分析
    Summary Black Rock Mining Ltd (BRML), formerly Green Rock Energy Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of graphite properties. It also holds interest in Mahenge Graphite Project which includes high-grade fl …
  • Policolor SA:企業の戦略的SWOT分析
    Policolor SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yamato Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Eurofins MWG Operon LLC-製薬・医療分野:企業M&A・提携分析
    Summary Eurofins MWG Operon LLC (Eurofins) is a biotechnology company that provides DNA sequencing, DNA synthesis and bioinformatic services. The company’s products include DNA tube oligos, large scale synthesis, large scale synthesis, oligo modifications, oligo modifications, real-time QPCR probes, …
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務情報
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆